Rosh Pharmaceuticals Corp

Multiple Choice

Rosh Pharmaceuticals Corp.is based in Israel but it maintains intellectual property protection of all its drugs with the Canadian Patent Office.If insufficient quantities of Rosh Pharmaceuticals Corp.'s newly patented pancreatic cancer drug are produced to meet demand in Canada,which of the following is most likely to be the result?

A) loss of intellectual property rights
B) licence to a Canadian facility
C) assignment to a Canadian facility
D) assignment of patent rights